Prevalence of SARS-CoV-2 among community members presenting for testing in Peoria, Illinois from 21 April to 15 May 2020
Expanding easily accessible community SARS-CoV-2 screening is essential in the response to the COVID-19 pandemic. In this report, we describe the findings from the initial 25 days of a SARS-CoV-2 drive-up and walk-up testing initiative was organized in Peoria, Illinois. Eighty-seven out of 4,073 ind...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Book |
| Published: |
Greater Baltimore Medical Center,
2021-01-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000 am a22000003u 4500 | ||
|---|---|---|---|
| 001 | doaj_1a1d7b2534c94cc49b876c20d414e8fd | ||
| 042 | |a dc | ||
| 100 | 1 | 0 | |a Tulika Chatterjee |e author |
| 700 | 1 | 0 | |a Manasa Kandula |e author |
| 700 | 1 | 0 | |a Mohammad O. Almoujahed |e author |
| 700 | 1 | 0 | |a Minchul Kim |e author |
| 700 | 1 | 0 | |a Kathryn Endress |e author |
| 700 | 1 | 0 | |a Gregg Stoner |e author |
| 700 | 1 | 0 | |a Monica Hendrickson |e author |
| 700 | 1 | 0 | |a Joseph Y. Kim |e author |
| 245 | 0 | 0 | |a Prevalence of SARS-CoV-2 among community members presenting for testing in Peoria, Illinois from 21 April to 15 May 2020 |
| 260 | |b Greater Baltimore Medical Center, |c 2021-01-01T00:00:00Z. | ||
| 500 | |a 2000-9666 | ||
| 500 | |a 10.1080/20009666.2020.1821470 | ||
| 520 | |a Expanding easily accessible community SARS-CoV-2 screening is essential in the response to the COVID-19 pandemic. In this report, we describe the findings from the initial 25 days of a SARS-CoV-2 drive-up and walk-up testing initiative was organized in Peoria, Illinois. Eighty-seven out of 4,073 individuals (2.1%) tested positive for SARS-CoV-2, and 46% of these were asymptomatic at the time of testing. There were ten frontline workers without symptoms consistent with COVID-19 who tested positive, including six that did not report any known exposure to SARS-CoV-2. These results stress the importance and effectiveness of widely available community SARS-CoV-2 testing and suggest a possible benefit to screening of asymptomatic individuals at higher risk for infection. | ||
| 546 | |a EN | ||
| 690 | |a sars-cov-2 | ||
| 690 | |a covid-19 | ||
| 690 | |a sars-cov-2 screening | ||
| 690 | |a covid-19 testing | ||
| 690 | |a covid-19 prevalence | ||
| 690 | |a asymptomatic covid-19 | ||
| 690 | |a Internal medicine | ||
| 690 | |a RC31-1245 | ||
| 655 | 7 | |a article |2 local | |
| 786 | 0 | |n Journal of Community Hospital Internal Medicine Perspectives, Vol 11, Iss 1, Pp 36-38 (2021) | |
| 787 | 0 | |n http://dx.doi.org/10.1080/20009666.2020.1821470 | |
| 787 | 0 | |n https://doaj.org/toc/2000-9666 | |
| 856 | 4 | 1 | |u https://doaj.org/article/1a1d7b2534c94cc49b876c20d414e8fd |z Connect to this object online. |